{"id":"W3174397236","doi":"10.2337/dc21-0300","title":"Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial","year":2021,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Relypsa; Cytokinetics; Astellas Pharma; Gilead Sciences; Servier; Satellite Healthcare; University of Glasgow; Kidney Research UK; Bristol-Myers Squibb; Akebia Therapeutics; Steno Diabetes Center Copenhagen; Quest Diagnostics; Novo Nordisk; ReCor Medical; Alnylam Pharmaceuticals; Kowa Company; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; GlaxoSmithKline; Defense Acquisition Program Administration; Amgen; Angion; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Dapagliflozin; Kidney disease; Prediabetes; Internal medicine; Renal function; Diabetes mellitus; Hazard ratio; Type 2 diabetes; Glycemic; Adverse effect; Urology; Endocrinology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001274936,0.0002025104,0.0005997199,0.00008128128,0.00006548403,0.00003722475,0.0001017923,0.00007236732,0.0003880603],"category_scores_gemma":[0.0002364228,0.0001430271,0.0002242815,0.000560922,0.00008292355,0.00005087299,0.0001277262,0.0001125914,0.00001371286],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005871007,"about_ca_system_score_gemma":0.00005830129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004853921,"about_ca_topic_score_gemma":0.00005071099,"domain_scores_codex":[0.9984756,0.0001301127,0.0003635661,0.0004120539,0.0003068212,0.0003118509],"domain_scores_gemma":[0.9983766,0.0006056296,0.0001151672,0.0006260774,0.0001442659,0.0001322348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.038713,0.001519026,0.7525176,0.0003425108,0.02084179,0.00004729797,0.005403153,0.0000676234,0.01208972,0.0001804843,0.03712137,0.1311564],"study_design_scores_gemma":[0.2795686,0.002771884,0.3234636,0.0005220016,0.03712982,2.604976e-7,0.01141432,0.001135533,0.03409764,0.0000989669,0.3089024,0.0008949726],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854887,0.01078428,0.0000248697,0.0005293899,0.0001177833,0.0007349864,0.0009707285,0.00004082641,0.001308472],"genre_scores_gemma":[0.9932808,0.0006699818,0.0002939457,0.0004556956,0.0001537156,0.00004442171,0.004709767,0.00002215273,0.0003695053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4290541,"threshold_uncertainty_score":0.5832477,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01217935964570861,"score_gpt":0.2498091595031481,"score_spread":0.2376297998574394,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}